Litigation

Recent Posts

$12.8M Verdict For Jaw Injury In Aredia/Zometa Case To Be Reduced To $1.14M
Posted on 24 Nov 2010 by Tom Moylan

WINSTON-SALEM, N.C. - (Mealey's) A North Carolina federal jury on Nov. 22 awarded $12,887,001 in an Aredia/Zometa jaw injury case, a verdict that will be reduced to $1,148,001 by North Carolina's limit on punitive damages ( Herbert Fussman, et... Read More

Novartis Wins Defense Verdict In Zometa Jaw Injury Trial
Posted on 26 May 2011 by Tom Moylan

BROOKLYN, N.Y. (Mealey's) A New York federal jury in the first federal Zometa trial found May 25 that the plaintiff did not prove by a preponderance of evidence that the Novartis Pharmaceuticals Corp. drug caused a decedent's osteonecrosis of... Read More

Novartis To Pay $422.5M In Marketing, Kickbacks Case
Posted on 1 Oct 2010 by LexisNexis Litigation Resource Community Staff

PHILADELPHIA - (AP) Novartis Pharmaceuticals Corp. will pay $422.5 million in penalties for marketing an epilepsy medicine for unapproved uses and for paying kickbacks to doctors to prescribe it and five other drugs, federal officials announced Thursday... Read More

NYC Jury: Novartis Discriminated Against Women
Posted on 17 May 2010 by LexisNexis Litigation Resource Community Staff

NEW YORK - (AP) A jury has decided that the drug company Novartis AG engaged in a pattern of discrimination against women, paying them less than men and treating pregnant women unfavorably. The verdict was returned Monday in Manhattan federal court... Read More